List of Verdeso drug patents
Verdeso is owned by Almirall.
Verdeso contains Desonide.
Verdeso has a total of 3 drug patents out of which 0 drug patents have expired.
Verdeso was authorised for market use on 19 September, 2006.
Verdeso is available in aerosol, foam;topical dosage forms.
Verdeso can be used as treatment of atopic dermatitis.
The generics of Verdeso are possible to be released after 13 August, 2027.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9492384 | ALMIRALL | Microemulsion and sub-micron emulsion process and compositions |
Aug, 2025
(2 years from now) | |
| US8962000 | ALMIRALL | Microemulsion and sub-micron emulsion process and compositions |
Aug, 2025
(2 years from now) | |
| US8460641 | ALMIRALL | Microemulsion process and composition |
Aug, 2027
(4 years from now) | |
Drugs and Companies using DESONIDE ingredient
Market Authorisation Date: 19 September, 2006
Treatment: Treatment of atopic dermatitis
Dosage: AEROSOL, FOAM;TOPICAL
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic